We serve Chemical Name:quinolin-3-ylmethylhydrazine CAS:887593-60-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:quinolin-3-ylmethylhydrazine
CAS.NO:887593-60-4
Synonyms:Quinolin-3-ylmethyl-hydrazine;3-quinolylmethylhydrazine
Molecular Formula:C10H11N3
Molecular Weight:173.21400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:50.94000
Exact Mass:173.09500
LogP:2.28930
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Quinolin-3-ylmethyl-hydrazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-quinolylmethylhydrazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Quinolin-3-ylmethyl-hydrazine Use and application,Quinolin-3-ylmethyl-hydrazine technical grade,usp/ep/jp grade.
Related News: Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API. quinolin-3-ylmethylhydrazine manufacturer Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly. quinolin-3-ylmethylhydrazine supplier A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters. quinolin-3-ylmethylhydrazine vendor Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high. quinolin-3-ylmethylhydrazine factory Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.
